SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oncolytics Biotech Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (11)6/6/2000 4:49:00 AM
From: blue_chip  Read Replies (1) of 103
 
NEWS

ONC (Toronto Stock Exchange) is 40% owned by Synsorb, full release at thenextwave.emerchantpro.com

Regards
Chip

FOR: ONCOLYTICS BIOTECH INC.

TSE, CDNX SYMBOL: ONC

JUNE 6, 2000

Oncolytics Biotech Inc. Announces Initiation of REOLYSIN
Clinical Study

CALGARY, ALBERTA--Oncolytics Biotech Inc. ("Oncolytics" or "the
Company") (TSE:ONC, CDNX:ONC) today announced that it has
initiated its first clinical study examining the use of REOLYSIN
in patients with cancer.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News